N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine Uses |
The application for the Intermediate named N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine is mentioned here below.
Please click on the Application name to browse through more details.
| Product Name | Cas No. | View |
|---|---|---|
| Imatinib | 152459-95-5 | View | Email |
Manus Aktteva Biopharma LLP offers Active Pharmaceutical Ingredients – APIs, Pharmaceutical Intermediates, Specialty Chemicals, Hazardous chemistry intermediates, Hazardous chemicals, Fine Chemicals, intermediates with Complex Chemistry, New Chemical Entities and Complex Carbohydrates APIs and intermediates. The products are offered for your R&D requirements from the manufacturer in India. We are open to offer in countries like Brazil, India, China, United States, Ethiopia, Argentina, Sudan, Pakistan, Mexico, Australia, Tanzania, Bangladesh, Colombia, Nigeria, Russian Federation, France, Kenya, Indonesia, Venezuela, Myanmar, South Africa, Turkey, Paraguay, Uganda, Germany, Canada, Uruguay, Niger, New Zealand, Uzbekistan, Madagascar, Mali, United Kingdom, Burkina Faso, Bolivia, Iran, Chad, Nepal, Ireland, Italy, Poland, Kazakhstan, Cameroon, Spain, Peru, Viet Nam, Zimbabwe, Thailand, Ecuador, Guinea,Egypt, Somalia, Angola, Ukraine, Belarus, CAR, Cuba, Japan, Zambia, Netherlands, Nicaragua, Senegal, Guatemala, South Korea, Chile, Morocco, Dominican Republic, Mongolia, Cambodia, Iraq, Honduras, Botswana, Philippines, Belgium, Azerbaijan, Namibia, Turkmenistan, Benin, Eritrea, Tajikistan, Romania, Austria, Algeria, Mauritania, Panama, Yemen, Lao People’s DR, Mozambique, Denmark, Ghana, Côte d’Ivoire, Switzerland, Sweden, Portugal, Haiti, Kyrgyzstan, Czech Republic, Costa Rica, Malawi, Sri Lanka, Rwanda, Georgia, SAR, Serbia, Finland, El Salvador, Norway, Burundi, Hungary, Malaysia, Congo, Lithuania, Greece, Guinea-Bissau, Lesotho, Armenia, Tunisia, Swaziland, Sierra Leone, Korea, Bulgaria, Saudi Arabia, Slovakia, Albania, Israel, Slovenia, Bosnia, Croatia, Gambia, Togo, Latvia, Puerto Rico, Oman, Bhutan, Congo, Fiji, Djibouti, Estonia, Macedonia, Libya, Luxembourg, Republic of Moldova, Vanuatu, Jamaica, Timor-Leste, Taiwan, Belize, Guyana, UAE, Papua New Guinea, New Caledonia, Montenegro, Lebanon, Guadeloupe, Jordan, Iceland, Cyprus, Comoros, Suriname, Liberia, Gabon, Kuwait, Trinidad, Palestinian Territory, Reunion, Samoa, Cabo Verde, French Guiana, Martinique, Malta, Solomon Islands, Dominica, Micronesia, Tonga, Barbados, Qatar, Saint Lucia, Bahrain, Montserrat, Virgin Islands, French Polynesia, Mauritius, Saint Kitts, Liechtenstein, Equatorial Guinea, Antigua, Saint Vincent, Grenada, Falkland Islands, BVI, Faroe Islands, Cayman Islands,Hong Kong, Sao Tome, Brunei, Bahamas, Saint Helena, Netherlands, Bermuda, Seychelles, Singapore, Guam, Cook Islands, Niue, American Samoa, Wallis, Saint Pierre, Greenland.
P.S.: This website is updated and maintained by Manus Aktteva Biopharma LLP. As a matter of policy, Manus Aktteva Biopharma LLP does not entertain any anonymous or pseudonymous inquiries.
